These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22152060)

  • 1. Selection of recombinant MVA by rescue of the essential D4R gene.
    Ricci PS; Schäfer B; Kreil TR; Falkner FG; Holzer GW
    Virol J; 2011 Dec; 8():529. PubMed ID: 22152060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
    Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
    PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.
    Erez N; Wyatt LS; Americo JL; Xiao W; Moss B
    J Virol; 2021 Sep; 95(19):e0110421. PubMed ID: 34232734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective vaccinia virus as a biologically safe tool for the overproduction of recombinant human secretory proteins.
    Himly M; Pfleiderer M; Holzer G; Fischer U; Hannak E; Falkner FG; Dorner F
    Protein Expr Purif; 1998 Dec; 14(3):317-26. PubMed ID: 9882565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced genetic rescue of negative-strand RNA viruses: use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors.
    Kovacs GR; Parks CL; Vasilakis N; Udem SA
    J Virol Methods; 2003 Jul; 111(1):29-36. PubMed ID: 12821194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vaccinia virus uracil DNA glycosylase catalytic site and deoxyuridine triphosphatase deletion mutations individually and together on replication in active and quiescent cells and pathogenesis in mice.
    De Silva FS; Moss B
    Virol J; 2008 Dec; 5():145. PubMed ID: 19055736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Recombinant MVA Selection Methods Based on F13L, D4R and K1L Genes.
    Antoshkina IV; Glazkova DV; Urusov FA; Bogoslovskaya EV; Shipulin GA
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncation of gene F5L partially masks rescue of vaccinia virus strain MVA growth on mammalian cells by restricting plaque size.
    Dobson BM; Tscharke DC
    J Gen Virol; 2014 Feb; 95(Pt 2):466-471. PubMed ID: 24145605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins.
    Wyatt LS; Xiao W; Americo JL; Earl PL; Moss B
    mBio; 2017 Jun; 8(3):. PubMed ID: 28588133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.
    Sperling KM; Schwantes A; Staib C; Schnierle BS; Sutter G
    J Virol; 2009 Jun; 83(12):6029-38. PubMed ID: 19357172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient host range selection for genetic engineering of modified vaccinia virus Ankara.
    Staib C; Drexler I; Ohlmann M; Wintersperger S; Erfle V; Sutter G
    Biotechniques; 2000 Jun; 28(6):1137-42, 1144-6, 1148. PubMed ID: 10868279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line.
    Holzer GW; Falkner FG
    J Virol; 1997 Jul; 71(7):4997-5002. PubMed ID: 9188564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.
    Ober BT; Brühl P; Schmidt M; Wieser V; Gritschenberger W; Coulibaly S; Savidis-Dacho H; Gerencer M; Falkner FG
    J Virol; 2002 Aug; 76(15):7713-23. PubMed ID: 12097585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference with SAMHD1 Restores Late Gene Expression of Modified Vaccinia Virus Ankara in Human Dendritic Cells and Abrogates Type I Interferon Expression.
    Sliva K; Martin J; von Rhein C; Herrmann T; Weyrich A; Toda M; Schnierle BS
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.
    García-Arriaza J; Gómez CE; Sorzano CÓ; Esteban M
    J Virol; 2014 Mar; 88(6):3392-410. PubMed ID: 24390336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
    Peng C; Moss B
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3759-3767. PubMed ID: 32019881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.
    Chahroudi A; Garber DA; Reeves P; Liu L; Kalman D; Feinberg MB
    J Virol; 2006 Sep; 80(17):8469-81. PubMed ID: 16912297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
    Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
    J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of recombinant vaccinia viruses.
    Earl PL; Moss B; Wyatt LS; Carroll MW
    Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.13. PubMed ID: 18429179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA).
    Jordan I; Horn D; Thiele K; Haag L; Fiddeke K; Sandig V
    Virol Sin; 2020 Apr; 35(2):212-226. PubMed ID: 31833037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.